Dupilumab in atopic dermatitis: rationale, latest evidence and place in therapy
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dupilumab in atopic dermatitis: rationale, latest evidence and place in therapy
Authors
Keywords
-
Journal
Therapeutic Advances in Chronic Disease
Volume -, Issue -, Pages 204062231877368
Publisher
SAGE Publications
Online
2018-05-11
DOI
10.1177/2040622318773686
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Use of systemic corticosteroids for atopic dermatitis: International Eczema Council consensus statement
- (2018) A.M. Drucker et al. BRITISH JOURNAL OF DERMATOLOGY
- Moving toward endotypes in atopic dermatitis: Identification of patient clusters based on serum biomarker analysis
- (2017) Judith L. Thijs et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Current guidelines for the evaluation and management of atopic dermatitis: A comparison of the Joint Task Force Practice Parameter and American Academy of Dermatology guidelines
- (2017) Lawrence F. Eichenfield et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies
- (2017) Patrick M. Brunner et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Therapeutic pipeline for atopic dermatitis: End of the drought?
- (2017) Amy S. Paller et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Impact of atopic dermatitis on health-related quality of life and productivity in adults in the United States: An analysis using the National Health and Wellness Survey
- (2017) Laurent Eckert et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial
- (2017) Andrew Blauvelt et al. LANCET
- Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
- (2017) NEW ENGLAND JOURNAL OF MEDICINE
- Expert Perspectives on Management of Moderate-to-Severe Atopic Dermatitis: A Multidisciplinary Consensus Addressing Current and Emerging Therapies
- (2017) Mark Boguniewicz et al. Journal of Allergy and Clinical Immunology-In Practice
- Drug survival for azathioprine and enteric-coated mycophenolate sodium in a long-term daily practice cohort of adult patients with atopic dermatitis
- (2016) J. van der Schaft et al. BRITISH JOURNAL OF DERMATOLOGY
- Clinical implications of new mechanistic insights into atopic dermatitis
- (2016) Donald Y.M. Leung CURRENT OPINION IN PEDIATRICS
- Atopic dermatitis
- (2016) Stephan Weidinger et al. LANCET
- Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial
- (2016) Diamant Thaçi et al. LANCET
- Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
- (2016) Eric L. Simpson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Drug survival for ciclosporin A in a long-term daily practice cohort of adult patients with atopic dermatitis
- (2015) J. van der Schaft et al. BRITISH JOURNAL OF DERMATOLOGY
- Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis
- (2014) Jennifer D. Hamilton et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis
- (2014) Lisa A. Beck et al. NEW ENGLAND JOURNAL OF MEDICINE
- Progressive activation of TH2/TH22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis
- (2012) Julia K. Gittler et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Atopic dermatitis results in intrinsic barrier and immune abnormalities: Implications for contact dermatitis
- (2012) Julia K. Gittler et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- 2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis
- (2012) Jasvinder A. Singh et al. ARTHRITIS CARE & RESEARCH
- Atopic dermatitis: a disease of altered skin barrier and immune dysregulation
- (2011) Mark Boguniewicz et al. IMMUNOLOGICAL REVIEWS
- Contrasting pathogenesis of atopic dermatitis and psoriasis—Part II: Immune cell subsets and therapeutic concepts
- (2011) Emma Guttman-Yassky et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Atopic Dermatitis
- (2010) Thomas Bieber Annals of Dermatology
- “Outside-to-Inside” (and Now Back to “Outside”) Pathogenic Mechanisms in Atopic Dermatitis
- (2008) Peter M. Elias et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Atopic Dermatitis
- (2008) Thomas Bieber NEW ENGLAND JOURNAL OF MEDICINE
- The Socioeconomic Impact of Atopic Dermatitis in the United States: A Systematic Review
- (2008) Anthony J. Mancini et al. PEDIATRIC DERMATOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started